{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:37:49Z","timestamp":1784986669556,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijcard.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T20:45:55Z","timestamp":1612989955000},"page":"112-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Sacubitril\u2013valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"330","author":[{"given":"Claudio","family":"Passino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sciarrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vergaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Spiesshoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.02.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013441","article-title":"Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction","volume":"8","author":"Vergaro","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0010","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jacc.2006.12.046","article-title":"Influence of obstructive sleep apnea on mortality in patients with heart failure","volume":"49","author":"Wang","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0020","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/01.CIR.99.11.1435","article-title":"Prognostic value of nocturnal Cheyne-stokes respiration in chronic heart failure","volume":"99","author":"Lanfranchi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/eurheartj\/ehv624","article-title":"Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients","volume":"37","author":"Oldenburg","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0030","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1378\/chest.07-0121","article-title":"Daytime Cheyne-stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality","volume":"132","author":"Brack","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jacc.2017.07.740","article-title":"Prognostic significance of central apneas throughout a 24-hour period in patients with heart failure","volume":"70","author":"Emdin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cardfail.2015.09.005","article-title":"After the SERVE-HF trial, is there still a need for treatment of central apnea?","volume":"21","author":"Emdin","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14779072.2017.1364626","article-title":"How to take arms against central apneas in heart failure","volume":"15","author":"Borrelli","year":"2017","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2005-864206","article-title":"Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options","volume":"26","author":"Javaheri","year":"2005","journal-title":"Semin Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0055","series-title":"The Breathless Heart","first-page":"247","article-title":"Targeting and treating apneas","author":"Passino","year":"2017"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0065","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of sleep medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.107.189420","article-title":"Sleep apnea and cardiovascular disease","volume":"118","author":"Somers","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5665\/sleep.2450","article-title":"Evaluation of a noninvasive algorithm for differentiation of obstructive and central hypopneas","volume":"36","author":"Randerath","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cardfail.2008.11.015","article-title":"Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction","volume":"15","author":"Yumino","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2019.00125","article-title":"Central and obstructive apneas in heart failure with reduced, mid-range and preserved ejection fraction","volume":"6","author":"Borrelli","year":"2019","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2008.06.028","article-title":"Risk factors and prognostic value of daytime Cheyne\u2013stokes respiration in chronic heart failure patients","volume":"137","author":"Poletti","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0100","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.jacc.2020.04.033","article-title":"Upright Cheyne-stokes respiration and prognosis in systolic heart failure","volume":"75","author":"Giannoni","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0105","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","article-title":"Adaptive servo-ventilation for central sleep apnea in systolic heart failure","volume":"373","author":"Cowie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0115","first-page":"1","article-title":"Association of Change in N-terminal pro\u2013B-type natriuretic peptide following initiation of Sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12435","article-title":"The reverse remodeling response to sacubitril\/valsartan therapy in heart failure with reduced ejection fraction","volume":"36","author":"Martens","year":"2018","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0125","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor Neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020262","article-title":"Early effects of Sacubitril\/valsartan on exercise tolerance in patients with heart failure with reduced ejection fraction","volume":"8","author":"Vitale","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0135","first-page":"1","article-title":"Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test","author":"Malfatto","year":"2019","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0140","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0145","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.jacc.2019.03.508","article-title":"No aldosterone breakthrough with the Neprilysin inhibitor Sacubitril","volume":"73","author":"Vergaro","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0150","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2018.12.063","article-title":"Effect of Neprilysin inhibition on various natriuretic peptide assays","volume":"73","author":"Ibrahim","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000455118","article-title":"Resolution of Cheyne-stokes respiration after treatment of heart failure with Sacubitril\/valsartan: a first case report","volume":"137","author":"Fox","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00392-015-0940-2","article-title":"Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea","volume":"105","author":"Fox","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ejhf.1402","article-title":"Reduced loop diuretic use in patients taking sacubitril\/valsartan compared with enalapril: the PARADIGM-HF trial","volume":"21","author":"Vardeny","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0170","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11325-018-1764-x","article-title":"Reduction of sleep-disordered breathing following effective percutaneous mitral valve repair with the MitraClip system","volume":"23","author":"Spiesshoefer","year":"2019","journal-title":"Sleep Breath."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijcard.2008.06.072","article-title":"Resolution of central sleep apnoea following implantation of a left ventricular assist device","volume":"138","author":"Vazir","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0180","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.transproceed.2014.06.063","article-title":"Delayed recovery from Cheyne-stokes respiration in heart failure after successful cardiac transplantation: a case report","volume":"46","author":"Fox","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0185","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/CIRCULATIONAHA.119.039920","article-title":"Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction","volume":"140","author":"Selvaraj","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0190","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","article-title":"B-type natriuretic peptide during treatment with Sacubitril\/valsartan","volume":"73","author":"Myhre","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0195","doi-asserted-by":"crossref","first-page":"111524","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and Neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.02.012_bb0200","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.1342","article-title":"Effects of sacubitril\/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study","volume":"21","author":"Nougu\u00e9","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2019.03.033","article-title":"Cheyne-stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure","volume":"289","author":"Giannoni","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0210","doi-asserted-by":"crossref","first-page":"100418","DOI":"10.1016\/j.ijcha.2019.100418","article-title":"Impact of sacubitril\/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation","volume":"25","author":"Bayard","year":"2019","journal-title":"IJC Heart Vasc."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122165","article-title":"The Effects of Sacubitril\/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The Hemodynamic Recovery","volume":"8","author":"Romano","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012419","article-title":"Contribution of the lung to the genesis of Cheyne-stokes respiration in heart failure: plant gain beyond Chemoreflex gain and circulation time","volume":"8","author":"Giannoni","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/CS20070292","article-title":"Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne\u2013stokes respiration and arrhythmias","volume":"114","author":"Giannoni","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0230","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2015.09.007","article-title":"Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure","volume":"202","author":"Giannoni","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11906-013-0368-x","article-title":"Role of the carotid body in the pathophysiology of heart failure","volume":"15","author":"Schultz","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11325-019-01868-6","article-title":"APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure","volume":"24","author":"Spiesshoefer","year":"2020","journal-title":"Sleep Breath."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0245","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1113\/jphysiol.2012.245159","article-title":"Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea","volume":"591","author":"White","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2021.02.012_bb0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2010.08.627","article-title":"Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications","volume":"57","author":"Kasai","year":"2011","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321002631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321002631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:50:46Z","timestamp":1759092646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"alternative-id":["S0167527321002631"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.012","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\u2013valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}